Company

Xiamen Amoytop Biotech

As of the edition of 20 October 2026, Xiamen Amoytop Biotech runs 5 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active4
Stopped1
Total5

Where its trials are

  • Digestive system: 4 trials led
  • Infections: 3 trials led
  • Hormones: 2 trials led